L-733,060 hydrochloride

Modify Date: 2024-01-11 17:39:19

L-733,060 hydrochloride Structure
L-733,060 hydrochloride structure
Common Name L-733,060 hydrochloride
CAS Number 148687-76-7 Molecular Weight 439.82200
Density N/A Boiling Point N/A
Molecular Formula C20H20ClF6NO Melting Point N/A
MSDS Chinese Flash Point N/A

 Use of L-733,060 hydrochloride


L-733060 hydrochloride is a potent tachykinin NK1 receptor antagonist. L-733060 hydrochloride inhibits neurogenic plasma extravasation at doses that do not cause adverse cardiovascular effects in rodents and also acts as an antitumoral agent[1][2].

 Names

Name (2R,3R)-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine,hydrochloride
Synonym More Synonyms

 L-733,060 hydrochloride Biological Activity

Description L-733060 hydrochloride is a potent tachykinin NK1 receptor antagonist. L-733060 hydrochloride inhibits neurogenic plasma extravasation at doses that do not cause adverse cardiovascular effects in rodents and also acts as an antitumoral agent[1][2].
Related Catalog
Target

NK1

In Vitro L-733060 (30-300 nM) inhibits the [Ca2+]i mobilisation caused by substance P (100 nM) in a concentration-dependent manner in human tachykinin NK1 receptor-transfected CHO cells[1]. L-733060 (2.5-20 μM; 48 and or 96 h) results in a concentration-dependent cytotoxicity in COLO 858 cells[2]. L-733060 (10-30 μM; 24 and 48 h) inhibits MEL H0 cells proliferation with IC50s of 27.5 μM and 18.9 μM at 24 h and 48 h, respectively[2]. L-733060 (20-50 μM; and or 72 h) inhibits COLO 679 cells growth with IC50s of 33.8 μM and 31.5 μM at 30 h and 72 h, respectively[2]. Cell Proliferation Assay[2] Cell Line: COLO 858 cells Concentration: 2.5, 5, 10, 20 μM Incubation Time: 0, 48, 96 h Result: Inhibited cells growth with IC50s of 8.7 μM and 7.1 μM at 48 h and 96 h, respectively.
In Vivo L-733060 (10-1000 μg/kg; i.v.) inhibits electrically stimulated plasma extravasation in dura mater of rats[1]. L-733060 (300-3000 μg/kg; i.v.) has no significant hypotensive or bradycardic effects are observed at doses of <3000 μg/kg in conscious or anaesthetised rats[1]. Animal Model: Male Sprague-Dawley rats (200 g) with electrical stimulation of the trigeminal ganglion[1] Dosage: 10, 100, 1000 mg/kg Administration: I.v. injection Result: Produced a significant dose-related inhibition of plasma extravasation with an ID50 of 212±19 μg/kg.
References

[1]. Seabrook GR, et, al. L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. Eur J Pharmacol. 1996 Dec 12; 317(1):129-35.

[2]. Muñoz M, et, al. Antitumoral action of the neurokinin-1 receptor antagonist L-733 060 on human melanoma cell lines. Melanoma Res. 2004 Jun;14(3):183-8.

 Chemical & Physical Properties

Molecular Formula C20H20ClF6NO
Molecular Weight 439.82200
Exact Mass 439.11400
PSA 21.26000
LogP 6.86490

 Safety Information

Safety Phrases 22-24/25
WGK Germany 3

 Synonyms

L-733,060 hydrochloride
(2S,3S)-3-[(3,5-bis(Trifluoromethyl)phenyl)methoxy]-2-phenylpiperidine hydrochloride
L-733,061 hydrochloride
L-733060 hydrochloride
Top Suppliers:I want be here




Get all suppliers and price by the below link:

L-733,060 hydrochloride suppliers

L-733,060 hydrochloride price